{"id":"https://openalex.org/W4240424238","doi":"https://doi.org/10.1002/14651858.cd008711.pub2","title":"Antifibrinolytic therapy to reduce haemoptysis from any cause","display_name":"Antifibrinolytic therapy to reduce haemoptysis from any cause","alternate_titles":[],"publication_year":2012,"publication_date":"2012-04-18","ids":{"openalex":"https://openalex.org/W4240424238","doi":"https://doi.org/10.1002/14651858.cd008711.pub2","pmid":"https://pubmed.ncbi.nlm.nih.gov/22513965"},"language":"en","primary_location":{"id":"doi:10.1002/14651858.cd008711.pub2","doi":"https://doi.org/10.1002/14651858.cd008711.pub2","is_oa":false,"landing_page_url":"https://doi.org/10.1002/14651858.cd008711.pub2","pdf_url":null,"source":{"id":"https://openalex.org/S4210172715","display_name":"Cochrane Database of Systematic Reviews","issn_l":"1361-6137","issn":["1361-6137","1464-780X","1465-184X","1465-1858","1469-493X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","jufo-2","ki-jl-2","medline","norway-1","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cochrane Database of Systematic Reviews","raw_type":"reference-entry"},"parent_works":[],"lineage":["https://openalex.org/W4240424238"],"child_works_count":0,"type":"reference-entry","is_traditional":false,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029155168","display_name":"Gabriela J. Prutsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriela Prutsky","raw_affiliation_strings":["Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067180099","display_name":"Juan Pablo Domecq","orcid":"https://orcid.org/0000-0002-8540-9862","observed_orcids":["https://orcid.org/0000-0002-8540-9862"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juan Pablo Domecq","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086352979","display_name":"Carlos A Salazar","orcid":"https://orcid.org/0000-0001-9959-8097","observed_orcids":["https://orcid.org/0000-0001-9959-8097"]},"institutions":[{"id":"https://openalex.org/I197097402","display_name":"Universidad Peruana Cayetano Heredia","ror":"https://ror.org/03yczjf25","country_code":"PE","type":"education","lineage":["https://openalex.org/I197097402"]}],"countries":["PE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carlos A Salazar","raw_affiliation_strings":["Universidad Peruana Cayetano Heredia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad Peruana Cayetano Heredia","institution_ids":["https://openalex.org/I197097402"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040277043","display_name":"Roberto A. Accinelli","orcid":"https://orcid.org/0000-0002-9773-8778","observed_orcids":["https://orcid.org/0000-0002-9773-8778"]},"institutions":[{"id":"https://openalex.org/I197097402","display_name":"Universidad Peruana Cayetano Heredia","ror":"https://ror.org/03yczjf25","country_code":"PE","type":"education","lineage":["https://openalex.org/I197097402"]},{"id":"https://openalex.org/I4210093192","display_name":"Hospital Nacional Cayetano Heredia","ror":"https://ror.org/00mtrzx11","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210093192"]}],"countries":["PE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roberto Accinelli","raw_affiliation_strings":["Departamento de Medicina, Universidad Peruana Cayetano Heredia and Hospital Nacional Cayetano Heredia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Medicina, Universidad Peruana Cayetano Heredia and Hospital Nacional Cayetano Heredia","institution_ids":["https://openalex.org/I197097402","https://openalex.org/I4210093192"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5100,"currency":"USD","value_usd":5100},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":44,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"4","first_page":"CD008711","last_page":"CD008711"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12548","display_name":"Hemostasis and retained surgical items","score":0.3582000136375427,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12548","display_name":"Hemostasis and retained surgical items","score":0.3582000136375427,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.10620000213384628,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11356","display_name":"Pleural and Pulmonary Diseases","score":0.10320000350475311,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hemoptysis","display_name":"hemoptysis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antifibrinolytic-agents","display_name":"antifibrinolytic agents","score":0.9639999866485596},{"id":"https://openalex.org/keywords/tranexamic-acid","display_name":"tranexamic acid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bleeding-time","display_name":"bleeding time","score":0.7540000081062317},{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.7229999899864197},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.5830000042915344},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6110000014305115},{"id":"https://openalex.org/keywords/low-income-countries","display_name":"low-income countries","score":0.671999990940094},{"id":"https://openalex.org/keywords/oral-tranexamic-acid","display_name":"oral tranexamic acid","score":0.6579999923706055},{"id":"https://openalex.org/keywords/intravenous-tranexamic-acid","display_name":"intravenous tranexamic acid","score":0.9879999756813049},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.33899998664855957},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.3799999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8835723400115967}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000933","descriptor_name":"Antifibrinolytic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000933","descriptor_name":"Antifibrinolytic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006469","descriptor_name":"Hemoptysis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006469","descriptor_name":"Hemoptysis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006469","descriptor_name":"Hemoptysis","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010568","descriptor_name":"Peru","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013785","descriptor_name":"Thailand","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014148","descriptor_name":"Tranexamic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014148","descriptor_name":"Tranexamic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/14651858.cd008711.pub2","doi":"https://doi.org/10.1002/14651858.cd008711.pub2","is_oa":false,"landing_page_url":"https://doi.org/10.1002/14651858.cd008711.pub2","pdf_url":null,"source":{"id":"https://openalex.org/S4210172715","display_name":"Cochrane Database of Systematic Reviews","issn_l":"1361-6137","issn":["1361-6137","1464-780X","1465-184X","1465-1858","1469-493X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","jufo-2","ki-jl-2","medline","norway-1","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cochrane Database of Systematic Reviews","raw_type":"reference-entry"},{"id":"pmid:22513965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22513965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Cochrane database of systematic reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W53122647","https://openalex.org/W134856236","https://openalex.org/W1967300023","https://openalex.org/W1972002411","https://openalex.org/W1977375151","https://openalex.org/W1979893512","https://openalex.org/W1980045397","https://openalex.org/W1980755080","https://openalex.org/W2018899738","https://openalex.org/W2023548647","https://openalex.org/W2028670834","https://openalex.org/W2032728373","https://openalex.org/W2036454015","https://openalex.org/W2042678233","https://openalex.org/W2056917177","https://openalex.org/W2061152996","https://openalex.org/W2064460339","https://openalex.org/W2070586531","https://openalex.org/W2075558842","https://openalex.org/W2076734821","https://openalex.org/W2080330736","https://openalex.org/W2085681856","https://openalex.org/W2091652504","https://openalex.org/W2091819951","https://openalex.org/W2095465279","https://openalex.org/W2107299782","https://openalex.org/W2125435699","https://openalex.org/W2139631775","https://openalex.org/W2140624242","https://openalex.org/W2162249417","https://openalex.org/W2162921010","https://openalex.org/W2336717694","https://openalex.org/W2419162654","https://openalex.org/W2616372265","https://openalex.org/W4231424981","https://openalex.org/W4234409358","https://openalex.org/W4237948199","https://openalex.org/W4247907436","https://openalex.org/W4251373224","https://openalex.org/W4252859197"],"related_works":["https://openalex.org/W4233388918","https://openalex.org/W7169814817","https://openalex.org/W7045577601","https://openalex.org/W1849905559","https://openalex.org/W7204583328","https://openalex.org/W1984040782","https://openalex.org/W4299349958","https://openalex.org/W2040200543","https://openalex.org/W2906423378"],"abstract_inverted_index":{"BACKGROUND:":[0],"Haemoptysis":[1],"is":[2,42,415],"a":[3,269,300,325,340],"common":[4],"pathology":[5],"around":[6],"the":[7,47,56,71,80,142,173,204,243,263,276,307,372,380,394,438],"world,":[8],"occurring":[9],"with":[10,110,192,210,293,317,339,354],"more":[11],"frequency":[12],"in":[13,40,54,62,89,107,118,126,180,183,273,287,304,312,328,393],"low-income":[14],"countries.":[15],"It":[16],"has":[17],"different":[18,35],"etiologies,":[19],"many":[20],"of":[21,51,60,75,82,84,86,104,135,145,177,188,194,201,206,262,278,295,309,345,365,374,383,396,440],"which":[22,241],"have":[23],"infectious":[24],"characteristics.":[25],"Antifibrinolytic":[26],"agents":[27,53,179,208],"are":[28],"commonly":[29],"used":[30,424],"to":[31,148,161,171,320,350,410,418,425],"manage":[32],"bleeding":[33,329],"from":[34,428],"sources,":[36],"but":[37,353],"their":[38],"usefulness":[39],"pulmonology":[41],"unclear.":[43],"OBJECTIVES:":[44],"To":[45],"evaluate":[46,172],"effectiveness":[48,174,277,308],"and":[49,58,64,79,94,132,138,175,185,197,225,251,291,335,402],"safety":[50,176],"antifibrinolytic":[52,105,178,207,283],"reducing":[55,181],"volume":[57],"duration":[59,439],"haemoptysis":[61,182,193,294,318,366,427],"adult":[63,184],"paediatric":[65,186],"patients.":[66],"SEARCH":[67],"METHODS:":[68],"We":[69,112,167,235,257],"searched":[70],"Cochrane":[72,91],"Central":[73],"Register":[74],"Controlled":[76],"Trials":[77],"(CENTRAL)":[78],"Database":[81],"Abstracts":[83],"Reviews":[85],"Effects":[87],"(DARE)":[88],"The":[90,199],"Library,":[92],"EMBASE":[93],"LILACS":[95],"for":[96,120,230],"publications":[97],"that":[98],"describe":[99],"randomized":[100,151,238],"controlled":[101,152,239],"trials":[102,122,153,240],"(RCTs)":[103],"therapy":[106],"patients":[108,187,315,332,336],"presenting":[109,191,316],"haemoptysis.":[111],"also":[113],"performed":[114,272,303],"an":[115,282],"independent":[116],"search":[117,157],"MEDLINE":[119],"relevant":[121,136,150,264],"not":[123,259,362,386],"yet":[124],"included":[125,146,168],"CENTRAL":[127],"or":[128,212],"DARE.We":[129],"conducted":[130],"electronic":[131,249],"manual":[133,255],"searches":[134],"national":[137],"international":[139],"journals.We":[140],"reviewed":[141],"reference":[143],"lists":[144],"studies":[147,265],"locate":[149],"(RCTs).":[154],"An":[155],"additional":[156],"was":[158,203,389],"carried":[159],"out":[160],"find":[162],"unpublished":[163],"RCTs.":[164],"SELECTION":[165],"CRITERIA:":[166],"RCTs":[169],"designed":[170],"both":[189],"genders":[190],"any":[195,261,429],"etiology":[196],"severity.":[198],"intervention":[200],"interest":[202],"administration":[205],"compared":[209],"placebo":[211,338,403],"no":[213,390],"treatment.":[214,375],"DATA":[215],"COLLECTION":[216],"AND":[217],"ANALYSIS:":[218],"All":[219],"reviewers":[220],"independently":[221],"assessed":[222],"methodological":[223],"quality":[224],"extracted":[226],"data":[227],"tables":[228],"pre-designed":[229],"this":[231],"review.":[232],"MAIN":[233],"RESULTS:":[234],"found":[236],"two":[237],"met":[242],"inclusion":[244],"criteria:":[245],"Tscheikuna":[246],"2002":[247],"(via":[248,254],"searches)":[250],"Ruiz":[252,298],"1994":[253],"searches).":[256],"did":[258,361],"exclude":[260],"we":[266],"found.Tscheikuna":[267],"2002,":[268],"double-blind":[270,301],"RCT":[271,302],"Thailand,":[274],"evaluated":[275,306,367],"tranexamic":[279],"acid":[280],"(TXA,":[281],"agent)":[284],"administered":[285],"orally":[286],"46":[288],"hospital":[289],"in-":[290],"outpatients":[292],"various":[296],"etiologies.":[297],"1994,":[299],"Peru,":[305],"intravenous":[310],"TXA":[311,334,360],"24":[313],"hospitalised":[314],"secondary":[319],"tuberculosis.Pooled":[321],"together,":[322],"results":[323],"demonstrated":[324],"significant":[326,391],"reduction":[327],"time":[330],"between":[331,400],"receiving":[333,337],"weighted":[341],"mean":[342],"difference":[343,392],"(WMD)":[344],"-19.47":[346],"(95%":[347],"CI":[348,408],"-26.90":[349],"-12.03":[351],"hours),":[352],"high":[355],"heterogeneity":[356],"(I\u00b2":[357],"=":[358],"52%).":[359],"affect":[363],"remission":[364],"at":[368],"seven":[369],"days":[370],"after":[371],"start":[373],"Adverse":[376],"effects":[377,399],"caused":[378],"by":[379],"drug's":[381],"mechanism":[382],"action":[384],"were":[385],"reported.":[387],"There":[388,414],"incidence":[395],"mild":[397],"side":[398],"active":[401],"groups":[404],"(OR":[405],"3.13,":[406],"95%":[407],"0.80":[409],"12.24).":[411],"AUTHORS'":[412],"CONCLUSIONS:":[413],"insufficient":[416],"evidence":[417,433],"judge":[419],"whether":[420],"antifibrinolytics":[421],"should":[422],"be":[423],"treat":[426],"cause,":[430],"though":[431],"limited":[432],"suggests":[434],"they":[435],"may":[436],"reduce":[437],"bleeding.":[441]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4240424238","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2022-05-12T00:00:00"}
